20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was ...

IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 March 10, 2026 2:00 PM EDTCompany ParticipantsMichael Feldschuh ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

The Elecsys pTau-181 test can help clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathology — an abnormal protein buildup in the brain associated with the ...

CNET dug into the latest speed test data to see how the country’s largest cable internet provider fared in national speed test data. Trey Paul was a CNET senior editor covering broadband. His 20+ ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

LH eyes growth via specialty test expansion, acquisitions and LaunchPad savings, but currency headwinds and macro pressures cloud the outlook.

Labcorp Holdings (LH) continues to attract attention after recent share price moves, with the stock last closing at $289.12. Investors are weighing this level against the company’s fundamentals in ...

Matt Kaeberlein, a longevity researcher, started TRT in his 50s. He said stigma and lack of information can make the process confusing.

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...